Evidence map›Paper›PMID 33854672›Full record

ArticleThe Pan African medical journal2021

Human papillomavirus, gene mutation and estrogen and progesterone receptors in breast cancer: a cross-sectional study.

Abdallah Mohammed Elagali, Ahmed Abdelbadie Suliman, Mohammed Altayeb, Anas Ibrahim Dannoun, Narasimha Reddy Parine, Hader Ibrahim Sakr, Howayda Saeed Suliman, Moustafa Elsaeid Motawee

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. HPV-Associated Breast Cancer: Myth or Fact?Pathogens (Basel, Switzerland) · 2022
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Abdallah Mohammed ElagaliFaculty of Medicine, Batterjee Medical College of Science and Technology, Jeddah, KSA.
Ahmed Abdelbadie SulimanPathology Department, Faculty of Medicine, Taibah University, Almadinah Almonawarah, Saudi Arabia.
Mohammed AltayebFaculty of Medicine, Batterjee Medical College of Science and Technology, Jeddah, KSA.
Anas Ibrahim DannounMolecular Genetics Department, Faculty of Medicine, Umm Al-Qura University, Mecca, KSA.
Narasimha Reddy ParineMedical Genetics Department, Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh, KSA.
Hader Ibrahim SakrPhysiology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo Governorate, Egypt.
Howayda Saeed SulimanDepartment of Biochemistry, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Moustafa Elsaeid MotaweeDepartment of Histology and Cytology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Al-Azhar University · EGAlexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionrecent studies show a good relationship between breast cancer (BC) and human papillomaviruses (HPV) wich is responsible for about 18% of BC cases. This study aimed to assess the relationship between different genotypes of HPV and the expression of P53 and retinoblastoma (RB) genes and estrogen and progesterone receptors in BC among Sudanese women.

methodsone hundred and fifty tissue blocks were obtained from females diagnosed with BC. Positive samples were used to determine genotypes with an applied biosystem (ABI 3730XL) genetic analyzer for sequencing and immunohistochemistry.

results13/150 samples showed HPV DNA. High-risk HPV-16 was detected in 5 cases, high-risk-HPV-58 was found in four cases, and HPV-18 was detected in three cases. Low-risk-HPV-11 was detected in a single invasive lobular carcinoma (ILC) case. P53 and RB gene mutations were detected in 35 and 30 BC cases, respectively. P53 gene mutation was frequently identified in grade (III) BC while RB gene mutation was positive in grade (II). Grade (II) BC had a higher incidence of HPV-16 and 58. On the other hand, HPV-18 had a higher incidence in grade (III). Estrogen and progesterone receptors were expressed in 94 and 79 HPV cases among the study group, respectively.

conclusionthis study elucidates the associations between HPV genotypes and BC. A statistically significant association was observed among p53 and RB gene mutations and different BC histological types. On the other hand, there was a statistically insignificant association between HPV genotyping and different BC gradings, BC histological types, P53 and RB genes mutations, and estrogen and progesterone receptor expression. Also, there was a statistically insignificant association among estrogen and progesterone receptors expression and BC grading. RB gene mutation was significantly associated with different BC grades. On the other hand, there was a statistically insignificant association between progesterone receptor expression and BC.

Indexed as

AlphapapillomavirusBreast NeoplasmsCross-Sectional StudiesDNA, ViralFemaleGene Expression Regulation, NeoplasticGenes, RetinoblastomaGenotypeHumansMutationPapillomavirus InfectionsReceptors, EstrogenReceptors, ProgesteroneSudanTumor Suppressor Protein p53DNA, ViralReceptors, EstrogenReceptors, ProgesteroneTP53 protein, humanTumor Suppressor Protein p53Breast cancerestrogen receptorshuman papillomavirusinvasive lobular carcinomap53 geneprogesterone receptorsretinoblastoma gene

Identifiers

PMID33854672
PMCPMC8017370
OpenAlexW3123316280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.